A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants
Clinical trial NCT05726851 · COMPLETED
Trial details
- NCT number
- NCT05726851
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-06
- Primary completion
- 2024-01-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.